Medical Properties Trust (NYSE:MPW) updated its FY 2020
Pre-Market earnings guidance on Thursday. The company provided earnings per share guidance of 1.68-1.71 for the period. Medical Properties Trust also updated its FY20 guidance to $1.68-1.71 EPS.
Several research firms recently weighed in on MPW. ValuEngine cut shares of Medical Properties Trust from a hold rating to a sell rating in a research report on Thursday, April 30th. TheStreet upgraded shares of Medical Properties Trust from a c+ rating to a b- rating in a research report on Thursday. KeyCorp dropped their price objective on shares of Medical Properties Trust from $25.00 to $20.00 and set an overweight rating for the company in a research report on Tuesday, April 21st. SunTrust Banks lifted their target price on shares of Medical Properties Trust from $19.00 to $20.00 and gave the stock a buy rating in a report on Thursday, June 25th. Finally, Zacks Investment Research lowered shares of Medical Properties Trust from a hold rating to a sell rating in a report on Wednesday, July 22nd. Two investment analysts have rated the stock with a sell rating, four have issued a hold rating and eight have given a buy rating to the company. Medical Properties Trust currently has an average rating of Hold and an average target price of $20.73.
Shares of MPW stock opened at $20.13 on Friday. Medical Properties Trust has a 12-month low of $12.35 and a 12-month high of $24.29. The firm has a market capitalization of $10.64 billion, a price-to-earnings ratio of 14.08, a price-to-earnings-growth ratio of 2.12 and a beta of 0.64. The company has a quick ratio of 4.04, a current ratio of 3.69 and a debt-to-equity ratio of 1.10. The firm has a fifty day moving average of $18.85 and a 200-day moving average of $19.20.
The company also recently announced a quarterly dividend, which was paid on Thursday, July 16th. Investors of record on Thursday, June 18th were given a $0.27 dividend. This represents a $1.08 dividend on an annualized basis and a yield of 5.37%. The ex-dividend date of this dividend was Wednesday, June 17th. Medical Properties Trust’s dividend payout ratio is presently 83.08%.
In other Medical Properties Trust news, Director Michael G. Stewart sold 5,000 shares of the business’s stock in a transaction that occurred on Wednesday, July 1st. The stock was sold at an average price of $19.09, for a total transaction of $95,450.00. Following the transaction, the director now owns 220,056 shares of the company’s stock, valued at approximately $4,200,869.04. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Edward K. Aldag, Jr. sold 156,569 shares of the business’s stock in a transaction that occurred on Tuesday, July 7th. The stock was sold at an average price of $18.60, for a total value of $2,912,183.40. Following the transaction, the chief executive officer now directly owns 3,229,184 shares in the company, valued at approximately $60,062,822.40. The disclosure for this sale can be found here. Insiders have sold a total of 581,569 shares of company stock worth $11,012,033 in the last ninety days. Insiders own 1.18% of the company’s stock.
Medical Properties Trust Company Profile
Medical Properties Trust, Inc is a self-advised real estate investment trust formed to capitalize on the changing trends in healthcare delivery by acquiring and developing net-leased healthcare facilities. MPT's financing model helps facilitate acquisitions and recapitalizations and allows operators of hospitals and other healthcare facilities to unlock the value of their real estate assets to fund facility improvements, technology upgrades and other investments in operations.
Featured Story: Most Active Stocks
Receive News & Ratings for Medical Properties Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Properties Trust and related companies with MarketBeat.com's FREE daily email newsletter.